Clinical Trials in North Carolina

Showing 16801-16820 of 20,428 trials

Gastrointestinal Tolerance of Infant Formula

NCT02322138

The study objective is to evaluate the gastrointestinal tolerance of infant formula supplemented with prebiotics.

Abbott Nutrition131 participantsStarted Jan 2015

Tucson, Arizona, United States • Colorado Springs, Colorado, United States • Norwich, Connecticut, United States +7 more locations

COMPLETEDPhase 241 miles

A 16 Weeks Study on Efficacy and Safety of Two Doses of Empagliflozin (BI 10773) (Once Daily Versus Twice Daily) in Patients With Type 2 Diabetes Mellitus and Preexisting Metformin Therapy

NCT01649297

The aim of this study is to investigate the efficacy and safety of two doses (high and low) of empagliflozin as add-on therapy to metformin in patients with type 2 diabetes mellitus (T2DM) and insufficient glycaemic control. Both doses may be given once daily or split to a twice daily dosage. This results in 4 different dosage regimens of empagliflozin (high dose once daily or split vs. low dose once daily or split). This is done to evaluate whether a twice daily dose regimen of empagliflozin results in a loss of efficacy relative to once daily dosing when given on top of metformin background therapy.

Diabetes Mellitus, Type 2

Boehringer Ingelheim983 participantsStarted Oct 2012

Florence, Alabama, United States • Jonesboro, Arkansas, United States • Lomita, California, United States +136 more locations

Gastrointestinal Tolerance of Infant Formula

A 16 Weeks Study on Efficacy and Safety of Two Doses of Empagliflozin (BI 10773) (Once Daily Versus Twice Daily) in Patients With Type 2 Diabetes Mellitus and Preexisting Metformin Therapy

Find Trials by Condition in North Carolina

Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects

Clinical Evaluation Of A New Two-Component Self-Etch Universal Adhesive

BAY 0 9867 Cipro Pediatric Use Study (QUIP)

A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis

The Oscillation for Acute Respiratory Distress Syndrome (ARDS) Treated Early (OSCILLATE) Trial

SynCardia Freedom Driver System Study

Prediction of Severity of Liver Disease by a 13C Octanoate Breath Test (OBT)

A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation for Elective Awake Fiberoptic Intubation

Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer

Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer

Spine Patient Outcomes Research Trial (SPORT) - Intervertebral Disc Herniation

Combination of GTI-2040 and Cytarabine in the Treatment of Refractory and Relapsed Acute Myeloid Leukemia (AML)

Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Resistant aHUS

A Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With Ovarian Cancer in Need of Relapse Treatment

A Phase II Clinical Trial of PXD101 in Patients With Recurrent or Refractory Cutaneous and Peripheral T-Cell Lymphomas

Safety and Efficacy Study of a Single Dose of NA-1 in Patients Undergoing Endovascular Repair of Ruptured Aneurysms

Follow-up Study After 11 Years of Patients Who Were Included in the BENEFIT Trial (304747) With a First Demyelinating Event Suggestive of Multiple Sclerosis

Chemotherapy Plus Surgery in Treating Patients With Stage III or Stage IV Ovarian, Peritoneal, or Fallopian Tube Cancer